Firstly, we observed a significant reduction in the proliferation rate of the MCF7 breast cancer cell line (expressing HR+/HER2− phenotype), associated with a significant blockade of the cell cycle and low levels of apoptosis. The gene discussed is ERBB2; the disease is breast carcinoma.